本文总结了373例按FAB标准诊断的骨髓增生异常综合征(MDS)患者,其中短期存活(<2年)205例(55％),中期存活(2～5年)105例(28％),长期存活(>5年)63例(17％),采用Bounnemouth、sanz、Lille三个积分系统把患者分为低、中和高危三组,对初诊时下列与预后相关的诸因素进行了统计学分析。这些参数为:年龄、性别、血红蛋白水平、外周血白细胞数、中性粒细胞数、单核细胞数、血小 This article summarizes 373 patients with myelodysplastic syndrome (MDS) diagnosed according to the FAB criteria, including 205 (55%) for short-term survival (<2 years) and 105 (28%) for medium-term survival (2-5 years) Long-term survival (> 5 years) 63 patients (17%), using Bounnemouth, sanz, Lille three integral system of patients were divided into low, medium and high risk groups, the prognosis of the following prognostic factors were statistically analysis. These parameters are: age, sex, hemoglobin level, peripheral blood leukocytes, neutrophils, monocytes, blood